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Objectives. This study was designed to determine in patients
with advanced coronary disease whether prediction of recovery of
mechanical function after coronary revascularizallon could be
accomplished more effectively by positron emission tomography
(PET) with carbon-11( 11C)-acetate than by PET with fluorine-18
('"F)-fluorodeoxyglucose .
Background. Results of previous studies have demonstrated
that preservation of myocardial oxidative metabolism (measured
by PET with "C-acetate) is necessary for recovery of systolic
function after coronary revascularizHon .
Methods. Myocardial oxidative metabolism was quantified
before revascularization in 34 patients by the analysis of the rate
of myocardial clearance of 11C-acetate. Metabolism of glucose was
assessed by analysis of uptake of 18F-fluorodeoxyglucose. Receiver
operating characteristic curves for predicting functional recovery
were derived for the measurements of oxidative metabolism and
glucose metabolism . In addition, criteria for prediction of recov-
ery of function based on measurements of oxidative metabolism
and glucose metabolism were developed and compared .
Results. Analysis of receiver operating characteristic curves
Selection of patients with impaired left ventricular systolic
function who would benefit from coronary revascularization
requires accurate differentiation of myocardium that is hi-
bernating or stunned but still viable from irreversibly in-
jured, nonviable tissue (1) . We and others have explored the
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indicated that estimates of oxidative metabolism were more robust
in predicting functional recovery than were estimates of glucose
metabolism (p < 0
.02) . Moreover, threshold criteria with "C .
act-tale exhibited superior positive and negative predictive values
(67% and 89%, respectively) than did the criteria with ' OF-
fluorodeoxygincose (52% and 81%, respectively), p < 0.01 . In
segments with initially severe dysfunction, estimates of oxidative
metabolism tended to be more robust than estimates of glucose
metabolism in predicting functional recovery . Moreover, in such
segments, the threshold criteria with "C-acetate tended to exhibit
superior positive and negative predictive values (85% and 87%,
respectively) than did the criteria with "T-fluorodeoxyglucose
(72% and 82% respectively), although statistical significance was
not achieved.
Conclusions . In patients with advanced coronary artery dis-
ease, the extent to which functional recovery can be anticipated
after coronary revascularization can be delineated accurately by
quantification of regional oxidative metabolism by PET with
11
C-acetate.
(J Am Coll Cardiol 1993,22 :1587- .97)
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feasibility of utilizing cardiac positron emission tomography
(PET) for this purpose . Initial clinical efforts have focused
on quantifying myocardial utilization of glucose with the
glucose analogue fluorine-l84uorodeoxyglucose in patients
with left ventricular dysfunction attributable to chronic coro-
nary artery disease (2,3) . Persistent myocardial utRization of
glucose, reflected by accumulation of "F-fluorodeoxyglucose,
has been shown to predict restoration of function after coro-
nary revascularization . Conversely, diminished utilization con-
cordant with the reduction in perfusion has been thought to be
indicative of irreversible injury (2-6) . Unfortunately, however,
PET with "3F-fluorodeoxyglucose overestimates the extent of
tissue viability in as many as 32% of myocardial segments and
underestimates tissue viability in up to 22% of segments
(2,3,6) . These discordances may in part reflect differences in
the pattern of substrates presented to the heart at the time of
myocardial imaging with 18F-fluoredeoxyglucose . These re-
0735-100,7193/56 .00
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suits also probably reflect the failure of uptake of "F-
fluorodeoxyglucose delineated with PET to identify meta-
bolic processes underlying viability sufficient for restoration
of myocardial systolic function (7) .
Under physiologic conditions, myocardial oxidative me-
tabolism is required to support contractile function (8,9) .
In
myocardium rendered ischemic but ultimately salvaged by
reperfusion, maintenance of oxidative metabolism is re-
quired for subsequent functional recovery (10,11) . We and
others (12-14) have shown that PET with "C-acetate can
accurately quantify regional myocardial oxidative mc .abo-
lism under conditions of normoxia, ischernia or reperfusion
and under diverse ventricular loading conditions, Further-
more, maintained oxidative metabolism has been found to be
a more robust descriptor of functional recovery compared
with maintained glucose utilization under several circum-
stances (15,16). Accordingly, it appeared likely that differr
endation of dysfunctional but viable myocardium from non-
viable tissue could be accomplished more effectively by
quantification of regional myocardial oxidative metabolism
by PET with "C-acetate than by measuring myocardial
utilization of glucose by PET with ' 8F-fluorodeoxyglucose .
Methods
Study patients. The protocol was approved by the Hu-
man Studies Committee and the Radioactive Drug Research
Committee of Washington University School of Medicine,
and written informed consent was obtained from each pa-
tient. Thirty-four patients (26 men and 8 women ; mean age
60 years range 30 to 77) who had left ventricular wall motion
abnormalities secondary to angiographically documented
coronary artery disease were studied . Twenty-one had bus-
tamed at least one myocardial infarction from I I days to 10
yon before enrollment in the study . In 17 patients, the
myocardial infarction had occurred at I month before enroll-
ment, Two patients had undergone coronary artery bypass
surgery 18 and 4 years earlier, respectively . Because the
kinetics of "F-fluorodeoxyglucose in myocardium. have not
been well delineated in patients with diabetes mellitus,
patients with known diabetes were excluded .
CWTAIW catheterization and selective coronary angiogra-
phy followed by coronary revascularization (coronary artery
bypass stulery or coronary artery angioplasty) were per-
Irmod in all patients. Eight had angiographically defined
lesions in a single vessel, 8 had lesions in two vessels and 18
had lesions in three vessels . In 24 patients, coronary artery
bypass VaRing 'Ams performed, and 10 underwent percuta-
Womus transluminal coronary angioplasty, The adequacy of
the revascuMiation, procedure was verified by review of
the operative reports documenting the successful placement
of bypass grafts and, in the case of coronary angioplasty, by
ROgiW*ic documeitation of successful balloon dilation .
None of the patients exhibited signs or symptoms of acute
myocardial infarction during the interval between the per-
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formance of the initial PET and waii motion studies and
performance of the follow-up wall motion stiv . 1y .
Assessment of ventricular function. For each patient, re-
gional systolic function was assessed before (mean 18 days,
range I to 65) and after (mean 2.0 months, range 0.5-7)
coronary revascularization . In 20 patients . regional systolic
function was assessed before and after revascularization by
two-dimensional echocardiography . In six patients, contrast
ventriculography was performed before and two-dimen-
sional echocardiography after revascularization . In six pa-
tients, radionuclide ventriculography was performed before
and after coronary revascularization . Two patients under-
went left ventricular ancury%niectomy at the time of revas-
cularization (see later) .
Regional systolic function was quantified as recently
described (15,16). For the purposes of analysis, the left
ventricular myocardium was segmented into eight regions
(septal, anterobasal, anterior, apical, lateral, posterolateral,
inferior and inferoposterior). With all three modalities (echo-
cardiography, radionuclide ventriculography and contrast
left ventriculography), regional systolic function was graded
according to the scoring system recommended by the Amer-
ican Society for Echocardiography (I = normal, 2 = hypo-
kinetic, 3 = akinetic, 4 = dyskinetic and 5 = aneurysmal)
(17). The wall motion analyses were performed by two
observers blinded to both PET and clinical data . The average
wall motion score reflecting values assigned by both observ-
ers was tabulated for each segment in each study .
As judged from the wall motion analyses, myocardial
segments were defined as: 1) normal ; 2) dysfunctional but
viable (initially dysfunctional segments [wall motion score
e21 that subsequently exhibited an improved wall motion
score of at least one full grade after revascularization) ; or
3) nonviable (persistently dysfunctional segments that did
not exhibit functional improvement) (15,16) . In the two
patients who underwent left ventricular aneurysmectomy,
only those segments that were resected were included in the
analysis because of the potential for misregistration of seg-
ments identified before and after revascularization conse-
quent to the altered left ventricular geometry that typically
occurs after aneurysmectomy . Extensive transmural necro-
sis and scarring were confirmed by gross and microscopic
analysis in each . Thus, the segments that were resected were
classified as nonviable. In patients who underwent coronary
artery bypass surgery, the interventricular septum was ex-
cluded from analysis because of abnormalities in contractile
performance independent of ischemia that occur frequently
in this region after surgery .
Tomographic assessment of perfusion and metabolism .
Tomographic assessments of perfusion and metabolism were
performed in all patients before coronary revascularization
(mean 12 days, range I to 38) . Positron emission tomo-
graphic studies were performed on average within 8 days
(range 1 to 56) of the assessments of systolic function .
Tomographic studies (IN that delineated the effects of
revascularization on myocardial perfusion, oxidative metab-
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olism and ghtcose .utilization in dysfunctional but viable and
nonviable myoca -Aium have previously peen reported for 16
of the patients in the current study .
The methods used to measure regional myocardial perfu-
sion, oxidative metabolism and utilization of glucose have
been reported recently in detail (15,16) . In brief, PET studies
were performed on standard PET instrumentation available
at Washington University (18-20). All subjects were studied
in the postprandial state after the consumption of a high
carbohydrate meal 2 to 3 h before and 75 g of glucose
(Trutol) I to 2 h before the administration of ' 8 17 -
fluorodeoxyglucose (15,16) . An initial transmission scan was
performed to correct subsequent emission scans for attenu-
ation . Carbon-i1-acetate (0.25 to 0.40 mCi/kg) was then
administered intravenously, followed by an 1,800-s list mode
data collection . Subsequently, ' 8 F-fluorodeoxyglucose (9 to
10 mCi) was administered intravenously, with an 1101s list
mode data collection performed 45 min later . To ensure that
each patient was positioned consistently within the PET
system for all data collections, position was checked with
the use of a low energy laser and indelible marks placed on
the torso .
Regional myocardial perfusion in relative terms was
based on the early myocardial uptake of "C-acetate. Results
of previous studies by our group and others (21,22) have
demonstrated that the regional distribution of activity within
the myocardium from 60 to 180 s after the administration of
"C-acetate accurately reflects regional myocardial perfusion
in relative terms. Myocardial oxidative metabolism was
quantified by determining the myocardial turnover rate con-
stant of acetate (k,), which reflects the rate of clearance of
"C activity from myocardium after the administration of
"C-acetate and correlates closely with regional myocardial
oxygen consumption (i2-14) . Regional myocardial utiliza-
tion of glucose was assessed on the basis of composite
images of relative "F-fluorodeoxyglucose activity .
Analysis of tomographic images was performed with an
operator-interactive method developed and validated in our
laboratory (23). All myocardial images were reformatted
from the transaxial orientation to true short-axis views, with
the heart divided into 8 to 12 tomographic slices on which
circumferential profiles of myocardial uptake of "C-acetate,
k, and '8F-fluorodeoxyglucose activity were generated for
each. The left ventricular myocardium was segmented as for
studies of wall motion, with distal slices comprising the left
ventricular apex, middle slices comprising anterior, lateral,
inferior and septal segments and basal slices comprising the
anterobasal, posterolateral and inferoposterior segments . By
reorienting the myocardial images and limiting the segmen-
tation of left ventricular myocardium to eight large seg-
ments, the risk of misregistration of the tomographic esti-
mates of perfusion and metabolism with the measurements
of regional wall motion was reduced .
Average values for myocardial uptake of "C-acetate, k,
and 1117-fluorodeoxyglucose activity were calculated for each
segment. Carbon-11 acetate myocardial uptake and 18F-
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fluorodeoxyglucose activity were
normalized to peak myocar-
dial activity for "C-acetate and 18F-fluorodeoxyglucose,
respectively, to yield relative values for myocardial blood
flow and utilization of glucose . In addition, myocardial
utilization of glucose was normalized to blood flow within
each segment by dividing normalized "F-Ruorodeoxy-
glucose activity by normalized myocardial uptake of "C-
acetate activity for the same segment, an approach analo-
gous to that described by others (24) .
Data analysis. Generation of receiver operating charac-
teristic curves . Receiver operating characteristic curves for
predicting functional recovery were derived from the indi-
vidual estimates of regional myocardial oxidative metabo-
lism, glucose metabolism and glucose metabolism normal-
ized to flow in the dysfunctional segments . The shape of
these curves reflects the performance of the measurements
of oxidative metabolism and glucose metabolism in predict-
ing functional recovery over a wide range of observed
values .
Generation of foinographic criteria of myocardial viabil-
ity. Although receiver operating characteristic curve analy-
sis is useful for evaluating the performance of a test, for the
purposes of clinical decision-making, threshold values must
be used. Consequently, tomographic criteria of tissue viabil-
ity and of nonviability were developed by referencing values
for oxidative metabolism and utilization of glucose to mean
values obtained in control subjects for each of the eight
segments . The control group consisted of 10 healthy normal
volunter -s (9 men; mean age 24 ± 3 years) with no history of
and a low likelihood for coronary artery disease . As judged
from measures of myocardial oxidative metabolism, dys-
functional but viable myocardium was considered present
when values for k, were within 2 SD of the mean value for a
particular segment in the control group . Conversely, non-
viable myocardium was considered present when values for
k, were lower than the mean value minus 2 SD in the control
group. These criteria were chosen on the basis of the
observation that in patients with chronic coronary artery
disease, the level of oxidative metabolism exhibited by
dysfunctional but viable myocardium was comparable to
that exhibited by normal myocardium. In contrast, the level
of oxidative metabolism exhibited by nonviable myocardium
was significantly lower than that in either normal or dysfunc-
tional but viable myocardium (16) . In the control subjects,
mean values and standard deviations for k, ranged from
0.052 ± 0.007 min- ' in apical segments to 0.057 ±
0.006 min - ' in inferior segments . Criteria using measure-
ments of myocardial utilization of glucose to identify viable
myocardium were analogo-is to those developed and vali-
dated by others (2,3)
. Dysfunctional but viable myocardium
was defined by values for regional myocardial utilization of
glucose within 2 SD of the mean value in the control group
(mean values ranged from 85 ± 11% in septal segments to
94 ± 7% in posterolateral segments) . Values for myocardial
utilization of glucose normalized to flow that were >2 SD
above the mean value in the control group were defined as
JACC Vol . 22, No . 6
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indicative of dysfunctional but still viable myocardium . In
the control subjects, mean values ranged from 0 .92 ± 0
.07 in
inferior segments to 0 .99 ± 0.14 in anterobasal segments
.
Conversely, reductions in myocardial utilization of glucose
(values >2 SD below the mean value in the control group)
that were not associated with increased utilization of glucose
normalized to flow were defined as indicative of nonviable
myocardium .
S ys . Continuous variables were assessed
in terms of mean values and standard d^.viations. The
comparisons of paired frequency data were performed with a
continuity-corrected McNemar test . Receiver operating
characteristic curves were compared with the methods of
Hanley and McNeil (25,26) . With this approach, it is as-
sumed that information is conveyed by a one-dimensional
variable X, with tow values of X su esting that tissue is
nonviable and high values suggesting that it is viable . Then if
N represents the distribution of the X values that are
associated with nonviable tissue and V represents the distri-
bution of the X values for viable tissue, the area A under the
receiver operating characteristic curve is given by :
A Probability (V > N) .
With this formulation, Hanley and McNeil (25) demon-
stratcd that the area under the receiver operating character-
istic curve along with the standard error of that area can be
computed with a standard Wilcoxon statistic . This is be-
cause the Wilcoxon statistic is by definition a measure of the
proportion of observed X values that are associated with
viable tissue that exceed a given X value that is associated
with nonviable tissue, summed over all X values that are
associated with nonviable tissue . Thus, the Wilcoxon statis-
tic is completely analogous to the area under the receiver
operating characteristic curve as just described . With this
formula, it is a simple matter to compute the standard error
(SE) of the difference between the areas under two uncorre-
lated receiver operating characteristic curves as ,
SE (Al A2)
$ 'SE' (A l) + SE 2 (A2),
and thereby to test the hypothesis of the equality of the areas
under two uncorrelated receiver operating characteristic
curves . In their second report, Hanley and McNeil (26)
extended this computation of standard errors in a natural
way to the case that applies herein, where the receiver
operating characteristic curves being compared are derived
from the same subject and are therefore correlate± . Proba-
bility (p) values < 0.05 were considered significant .
Results
Systolic As judged from the wall motion analy-
ses, 131 segments were identified as normal and 141 seg-
ments as dysfunctional . Twenty-five of the dysfunctional
segments were excluded from fin-her analysis because of
1)
location in interveatricular septum in patients undergoing
coronary artery bypass surgery (n = 15)
; 2) location not
completely within the field of view of the scanner during
tomographic imaging (n = 4) ; 3) incomplete revasculariza-
tion (n = 4) ; and 4) failure to completely characterize
systolic function before and after coronary revascularization
(n = 2) . Among the 116 dysfunctional segments that were
included in the analysis, 46 were classified as dysfunctional
but viable and 70 as nonviable . Before revascularization,
both types of dysfunctional myocardium exhibited similar
mechanical impairment, with dysfunctional but viable myo-
cardium exhibiting an average wall motion score of 2 .72 ±
0.74 and nonviable myocardium showing an average wall
motion score of 2 .68 ± 0.91 (p = NS) . After coronary
revascularization, segments classified as dysfunctional but
viable exhibited improvement in systolic wall function (in
accordance with our original definition), with au average
wall motion score of 1 .28 ± 0.56. Conversely, regional wall
motion in dysfunctional segments classified as nonviable did
not change appreciably as evidenced by an average wall
motion score after revascularization of 2 .08 ± 0.89 (mean
change 0.01 ± 0 .30). Severe systolic dysfunction was
present in 26 segments (from 13 patients) classified as
dysfunctional but viable ; these segments exhibited akinetic
to frank aneurysmal changes (wall motion score ~3) before
coronary revascularization . Thirty-one segments (from 14
patients) classified as nonviable exhibited similarly severe
impairment of function before coronary revascularization .
To determine the reproducibility of the estimates of
regional systolic function, the paired wall motion studies
from 10 paticats (six paired echocardiograms, two paired
radionuclide ventriculograms and two contrast left ventric-
ulograms paired with echocardiograms) were chosen at
random and reanalyzed . The wall motion analysis was
performed by the same two observers who performed the
initial analyses and who were blinded to the tomographic and
clinical data as well as the wall motion scores assigned
initially . In 38 dysfunctional segments, the average wall
motion score calculated on repeat analysis was comparable
to that calculated initially both before (2 .46 ± 0.74 and
2.64 ± 0.74, respectively, p = NS, average percent differ-
ence 10.2 ± 19.0%) and after (1 .88 ± 0 .74 and 1 .89 ± 0 .81,
respectively, p = NS, average percent difference between
the two measurements 7 .8 ± 17.5%®) coronary revasculariza-
tion . Moreover, the changes in systolic function in response
to coronary revascularization calculated on the repeat anal-
ysis (average change 0 .76 ± 0.63) were comparable to those
estimated initially (0.82 ± 0.71, p = NS, average percent
difference between the two measurements (18 ± 30%) .
Tomographic criteria and functional outcome for all dys-
functional segments. Analysis of receiver operating charac-
teristic curves . The receiver operating characteristic curves
for predicting functional recovery generated for the mea-
surements of oxidative metabolism and glucose metabolism
are shown in Figures 1 and 2 . Examples of dysfunctional but
viable myocardium and nonviable myocardium are illus-
trated in Figures 3 and 4, respectively. The receiver operat-
ing characteristic curve reflecting measurements of regional
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Figure 1 . Receiver operating characteristic curves for prediction o f
functional recovery based on measurements of regional myocardial
blood flow (MBF), oxidative metabolism, glucose metabolism and
glucose metabolism normalized to flow . Measurements of oxidative
metabolism were the most accurate as evidenced by the left and
upward shift of the receiver operating characteristic curve for these
measurements (area under the curve 0 .79 ± 0.05) compared with the
curves reflecting estimates of myocardial blood flow (area under
the curve 0.58 ± 0 .06, p < 0.008), glucose metabolism (area under the
curve 0.63 ± 0 .05, p < 0 .007) and glucose metabolism normalized to
flow (area under the curve 0 .63 ± 0.05, p < 0.02) .
perfusion are displayed for comparison purposes . The rela-
tively linear shape of this curve (area under the curve 0 .58
0.06) suggests that measurements of relative flow alone
were
not useful in delineating viable myocardium . Measurements
Figure 2 . Receiver operating characteristic curves for predicting
functional recovery in segments exhibiting severe dysfunction ini-
tially . Again, measurements of oxidative metabolism tend to be the
most accurate in predicting functional recovery (area under the
curve 0.78 ± 0.06) relative to the curves reflecting measurements of
myocardial blood flow (MBF) (area under the curve 0 .61 ± 0 .08, p <
0.02), glucose metabolism (area under the curve 0 .72 ± 0.07, p =
NS) and glucose metabolism normalized to flow (area under the
curve 0.64 ± 0.07, p = NS).
MBF
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of oxidative metabolism were the most accurate in delineat-
ing viable myocardium as evidenced by the left, and upward
shift of the receiver operating characteristic curve for these
measurements (area under the curve 0 .79 ± 0.05) compared
with the curves reflecting estimates of glucose metabolism
(area under the curve 0.63 ± 0.05, p < 0.007) and glucose
metabolism normalized to flow (area under the curve 0.63
0.05, p < 0.02) (Fig. 1) .
Accuracy of threshold criteria for predicting functional
olutcome . .A.s judged from the kinetics of myocardial clear-
ance of "C-acetate activity measured before revasculariza-
tion, 60 segments were identified as dysfunctional but viable
and 56 segments were classified as nonviable . Before revas-
cularization, 73 segments were classified as dysfunctional
but viable as judged from the regional distribution of ' BF-
fluorodeclxyglucose activity in myocardium ; 56 segments
exhibited, values of regional ' BF-fluorodeoxyglucose activity
within 2 SD of the mean value in the control group and 17
segments exhibited augmented utilization of glucose relative
to flow . Conversely, 43 dysfunctional segments were classi-
fied as nonviable because they exhibited reduced myocardial
accumulation of "1F-fluorodeoxyglucose.
Sixty-seven percent of segments initially classified as
dysfunctional but viable on the basis of PET with 11 C-acetate
exhibited functional improvement after revascalarization . In
contrast, only 52% of the 73 segments initially classified as
dysfunctional but viable on the basis of PET with ' BF-
fluorodeoxyglucose exhibited improvement in systolic func-
tion (p < 0.01 compared with "C-acetate) (Table 1) . In the
56 segments that were classified as dysfunctional but viable
as judged from ' BF-fluorodeoxyglucose activity alone, 55%
exhibited functional improvement after revascularization . In
the subset of 17 segments classified as dysfunctional but
viable based on the presence of augmented utilization of
glucose normalized to flow, only 7 (41%) exhibited func-
tional recovery after revascularization . Examples of discor-
dant segment classification based on results with "C-acetate
and i8F-fluorodeoxyglucose are shown in Figures 5 and 6
. In
dysfunctional segments initially classified as nonviable by
PET with 11 C-acetate, 89% exhibited no functional improve-
ment after coronary revascularization . In contrast, 81% of
dysfunctional segments initially classified as nonviable by
PET with 18
F-fluorodeoxyglucose exhibited no improvement
after revascularization (p < 0 .01 compared with "C-acetate)
(Table 1) .
To determine if estimates of regional myocardial perfu-
sion alone could differentiate viable from nonviable myo-
cardium, criteria based on early myocardial uptake of
"C-acetate were compared with functional outcome
. Dys-
functional but viable myocardium was considered to be
present when values for myocardial uptake of "C-acetate
were within 2 SD of the mean value in the control group for
a particular segment
. Conversely, nonviable myocardium
was considered to be present when values for myocardial
uptake of "C-acetate were lower than the mean value minus
2 SD in the control group
. In dysfunctional segments classi-
1 592
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fled as viable, 45% (34 of 75) exhibited functional improve-
ment after revascularization. Conversely, 68% (28 of 41) of
dysfunctional segments classified as nonviable did not ex-
hibit functional improvement (p < 0 .01 compared with the
myocardial clearance of 11C-acetate) .
Tomographic criteria and functional outcome for severely
dyshndional segments . Analysis of receiver operating char-
acteristic curves . Delineation of the capacity for functional
recovery is particularly difficult in regions of severe impair-
JACC Vol, 22, No . 6
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mew. Yet, it is of particular clinical importance . Con,--e-
quently, we performed a separate analysis on dysfunctional
segments that exhibited frank akinetic to aneurysmal
changes before coronary revascularization (Fig . 2) . In the
severely dysfunctional segments, measurements of oxidative
metabolism tended to be better for predicting functional
recovery as evidenced by the left and upward shift of the
receiver operating characteristic curve (area under the curve
0.78 ± 0.06) relative to the curves reflecting measurements
Figure 4. Flow and metabolism before revascu-
larization in the anterior wall in dysfunctional
but viable myocardium (akinesia present ini-
tially, with normal function after revasculariza-
tion) . In the anterior wall, both flow and glucose
utilization are within the normal range predic-
tive of functional recovery . Myocardial oxida-
tive metabolism in the anterior wall is within the
normal range as well . Abbreviations as in Fig-
ure 3 .
Figure 3 . Flow and metabolism before revascu-
larization in nonviable myocardium in the infe-
rolateral wall . The midventricular images of
flow (upper left) and glucose utilization (upper
right) are displayed in true short-axis orienta-
tion . The lateral wall is at 90° and the anterior
wall is at 180' . At the lower left are circumfer-
ential profiles of the relative values for regional
perfusion (blue interrupted curve) and glucose
utilization (yellow interrupted curve) . Profiles
representing the lower limits of normal (derived
from the 10 normal control subjects) for re-
gional flow and glucose utilization are depicted
by the solid red and white curves, respectively .
At the lower right is the profile representing
regional values for the myocardial turnover rate
constant of acetate (k) for this patient (blue
interrupted curve) superimposed on the profile
dc jiicting the lower limits of normal (white solid
curve) . Myocardial blood flow (MI3F) and utili-
zation of glucose are reduced concordantly in
the inferolateral wall, decreasing to less than
the lower limits of normal, a pattern consistent
with nonviable myocardium . Myocardial oxidu-
live metabolism in the inferolateral wall also
decreases to less than the lower limits of normal
for this region, consistent with nonviable myo-
cardium .
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Table 1. Tomographic Criteria of Myocardial Viability and
Functional Outcome
*p < 0 .01 compared with fluorine- 18-fluorodeoxyglucose .
of glucose metabolism nd glucose metabolism normalized
to flow (area under the curve 0 .72 ± 0.07 and 0 .64 ± 0.07,
respectively), but these differences did not achieve statistical
significance,
Accuracy of drreshold criteria fiw pr°edBiimy recovery of`
finiction . Among segments exhibiting severe, impairment in
systolic function before revascularization that were classi-
fied as dysfunctional but viable by PET with "C-acetate,
85% exhibited functional improvement after revasculariza-
tion. However, among segments classified as dysfunctional
but viable by PET with ' 8F-fluorodeoxyglucose before re-
vascularization, only 72% exhibited improved systolic func-
tion after reva .,cularization (p = NS) (Table 2) . Among the
22 segments classified as dysfunctional but viable based on
the level of 18 17-fluorodeoxyglucose activity alone, 73% (n =
16) exhibited functional improvement after revasculariza-
tion. Among the seven segments classified as viable on the
basis of the presence of augmented utilization of glucose
normalized to flow, 71% (n = 5) exhibited functional recov-
ery after revascularization .
In severely dysfunctional segments classified as nonvia-
ble by PET with "C-acetate, 87% did not improve after
coronary revascularization. Eighty-two percent of severely
dysfunctional segments classified as nonviable by PET with
' 8F-fluorodeoxyglucose failed to exhibit improvement in
systolic function after revascularization (p = NS) .
In severely dysfunctional segments classified as viab le on
the basis of flow estimates, 56% (18 of 32) exhibited func-
tional improvement after coronary revascularizatian . Sixty-
eight percent (17 of 25) of severely dysfunctional -egments
classified as nonviable on the basis of flow estimates failed to
exhibit improvement in mechanical function after revascu-
larization (p < 0.05 compared with myocardial clearance of
G I I acetate) .
Discussion
Our results indicate that in patients with left ventricular
dysfunction attributable to predominantly chronic coronary
artery disease, regional estimates of overall myocardial
oxidative metabolism by PET with 11C .-acetate can accu-
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rately identify dysfunctional but still viable myocardium
capable of recovering systolic function after coronary revas-
cularization . They indicate that the estimates are more
robust and superior to those acquired with a tracer that is not
specific for oxidative metabolism .
Delineation of viable myocardium by
fluorine-18-
fluorodeoxyglucose. Accelerated utilization of glucose (at-
tributable to both anaerobic and aerobic glycolysis) is char-
acteristic of myocardium rendered ischemic (27) .
Consequently, initial efforts to delineate dysfunctional but
viable myocardium by PET focused on assessing levels
of myocardial utilization of glucose with ' 8 F-
fluorodcoxyglucose in relation to functional outcome (2,3) .
In humans with left ventricular dysfunction attributable to
chronic coronary artery disease, the persistence of myocar-
dial utilization of glucose (whether or not hypoperfusion was
present) identified myocardium capable of functional recov-
ery after coronary artery bypass surgery in 78% to 85%
of cases (2,3) . Conversely, reduced myocardial utilization
of glucose (concordant with reduced perfusion) identified
dysfunctional myocardium that failed to improve in 78%
to 92% of cases (2,3) . Accordingly, PET with 180
fluorodeoxyglucose has been considered by many to be
useful for differentiating dysfunctional but viable from non-
viable myocardium (4-6) .
Recently, positive and negative predictive values of 68%
and 79%, respectively, for identifying viable myocardium
with this approach have been reported (6) . Thus, PEI" with
`F-fluorodeoxyglucose will overestimate the extent of tis-
sue viability in up to 32% of myocardial segments and
underestimate the extent of tissue viability in up to 22% of
segments (3,6) . The discordances may be explained in part
by the differences in the protocols used to standardize the
substrate environment for myocardial imaging with "F-
fluorodeoxyglucose in the various studies (for example,
lower predictive values were reported when patients were
studied under fasting conditions than when they were stud-
ied in the glucose-loaded state) (2,3,6) . However. these
inaccuracies probably also reflect the relative nonspecificity
of myocardial kinetics of 18 F-fluorodeoxyglucose with re-
spect to oxidative compared with nonoxidative myocardial
glucose metabolism (7,28) . Indeed, it was recently shown
that myocardial accumulation of ' 4 C-deoxyglucose does not
reflect glycolysis during reperfusion, whether or not hyper-
glycemia was present initially (7) . Consequently, PET with
' S F-fluorodeoxyglucose may not be capable of specifically
identifying those metabolic processes required for the recov-
ery of function of myocardium rendered ischemic .
Oxidative metabolism and myocardial viability . Under
physiologic conditions, maintenance of myocardial oxidative
metabolism is required for continued contractile function
(8,9) . In experimental animals subjected to myocardial isch-
emia and successful reperfusion, recovery of contractile
performance is associated %,, ith recovery of oxidative metab-
olism (10,11)
. Until recently, the lack of availability of
methods for measurement of regional myocardial oxidative
wall Motion
(no . of segments)
Improved
Not
unproved
Predictive
Value (70
Fluorine- 184uorodeoxyglucose
Viable 38 35 52
Nonviable 8 35 81
Carbon-11-acetate
Viable 40 20 67*
Nonviable 6 50
89*
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metabolism precluded assessments in human subjects. How-
ever, results of studies by our group and others (12-14) have
demonstrated that PET with acetate can provide accurate
estimates of regional overall myocardial oxidative metabo-
lism under conditions of normoxia, ischemia and reperfu-
sion. Using this approach in conjunction with PET and
' IF-fluorodeoxyglucose, we demonstrated that preservation
of overall myocardial oxidative metabolism is a necessary
condition for the recovery of function after revascularization
JACC Vol . 22 . No . 6
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Figure 5. Nonviable myocardium (based on
assessments of function before and after re-
vascularization) in the inferior wall, where
criteria for myocardial viability based on
fluorine- I 8-fluorodeoxyglucose and carbon-
1I-acetate determined before revasculariza-
tion were discordant . In the inferior wall,
glucose utilization is increased relative to
flow, a pattern considered typically to be
indicative of viable myocardium . In contrast,
Oxidative metabolism is reduced in the infe-
rior wall consistent with nonviable myocar-
dium. Augmented myocardial utilization of
glucose relative to flow in the presence of
reduced oxidative metabolism suggests that
the preserved glucose utilization is primarily
anaerobic, a condition incapable of maintain-
ing tissue viability in the long term . Abbrevi-
ations as in Figure 3,
in patients with left ventricular dysfunction attributable to
either acute or chronic coronary syndromes (15,16) . Further-
more, results from these studies suggested that preservation
of myocardial of glljco~e (particularly in the
presence of hypoperfusion) predicted functional recovery
only when the metabolic pattern in the tissue reflected
primarily oxidative utilization of glucose . Accordingly, it
appeared likely that "C-acetate would more effectively
predict improvement in mechanical function after coronary
Figure 6. Viable myocardium (based on
assessments of function before and after
revascularization) in the inferior wall,
where criteria for myocardial viability
based on fluorine- 18-fluorodeoxyglucose
and carbon- I I-acetate determined before
revascularization were discordant . In the
inferior wall, myocardial utilization of glu-
cose is reduced (as is flow), suggesting the
presence of nonviable myocardium . How-
ever, oxidative metabolism is maintained
in the normal range consistent with viable
tissue . Reduced myocardial utilization of
glucose in the presence of preserved oxi-
dative metabolism suggests other sub-
strates (probably fatty acids) were being
used to support oxidative metabolism . Ab-
breviations as in Figure 3.
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Table 2
. Toniographic Criteria of Myocardial viability and
Functional Outcome in Severely Dysfunctional Segments*
*Dysfunctional segments exhibiting akinelic to aneurysmal changes be-
fore coronary revascularization .
revascularization . The findings in the present study demon-
strate that PEI' with "C-acetate is superior to PET with
"'F-fluorodeoxyglucose for this purpose (Tables I and 2 ; Fig .
1, 2, 5 and 6) .
Because of the close coupling of myocardial oxygen
consumption and perfusion, it has been theorized that esti-
mates of myocardial oxidative metabolism by PET with
"C-acetate would not be better discriminators of myocardial
viability than estimates of flow, The findings in the present
study suggest this is not the case in patients with left
ventricular dysfunction attributable to chronic coronary
artery disease . Quantification of myocardial oxidative me-
tabolism better differentiated viable and nonviable myocar-
dium than did estimates of relative flow, regardless of the
severity of the mechanical dysfunction present initially .
Quantification of regional myocardial perfusion in absolute
terms might have improved the accuracy of the flow criteria
for identifying viable myocardium . However, the findings in
the present study are consistent with previous reports
(16,29,30) suggesting that although a parallelism exists be-
tween blood flow and oxygen consumption in myocardium
rendered ischemic, the actual correlation differs from that
observed in normal myocardium (probably because of in-
creased extraction of oxygen by ischemic myocardium) .
Comparison with previous studies . On first inspection, the
finding that only 67% and 52% of segments identified as
dysfunctional but viable based on PET with "C-acetate and
with "F-fluorodeoxyglucose, respectively, exhibited im-
provement in systolic function after coronary revasculariza-
tion is somewhat surprising. Although none of the patients
exhibited clinical evidence of aortocoronary bypass graft
closure or restenosis of a native coronary artery, subclinical
occurrences of these phenomena may have lowered the
predictive values for both tracers . However, the relatively
short interval from revascularization to the follow-up mea-
surement of systolic function (average 2 months) and th
lack of symptoms reduce the likelihood that graft closure (,,,
coronary restenosis contributed significantly to the results .
The large number of segments (59 of 116) classified as
hypokinetic before coronary revascularization is a more
GROPLER ET AL,
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likely contributing factor
. Such segments must have con-
tained some myocardium that maintained residual contrac-
tile function (and thus was active metabolically)
. The scoring
system used in the present study does not compensate for
the severity of wall motion abnormalities in segments iden-
tified as hypokinetic (that is, mild, moderate or severe) .
Consequently, dysfunctional segments defined as initially
hypokinetic (initial wall motion score 2 to 2
.9) before coro-
nary revascularization would have had to exhibit normal or
near normal wall motion after revascularization to be clas-
sified as dysfunctional but viable . In contrast, a dysfunc-
tional segment with an initial wall motion score of 3 would
have had to exhibit a wall motion score after revasculariza-
tion of only 2 to be classified as dysfunctional but viable .
Indeed, among segments with severe dysfunction before
revascularization, the positive predictive values for both
PET with "C .-acetate and with 18F-fluorodeoxyglucose were
higher (Table 2) . Thus, it appears that criteria for differenti-
ating dysfunctional but viable from nonviable myocardium
on the basis of measurements of myocardial metabolism are
most accurate when applied to severely dysfunctional myo-
cardium-regions for which the distinction between viability
and nonviability is of most clinical importance .
The positive and negative predictive values (based on
18F-fluorodeoxyglucose criteria) of 72% and 82%, respec-
tively, for segments exhibiting severe dysfunction initially
are consistent with values reported by Tamaki et al . (3) (78%
for both) and Marwick et al . (6) (positive predictive value of
68% and negative predictive value of 79%) . The lower
negative predictive values (Tables I and 2) in the current
study may have been related in part to posttest referral bias .
In approximately 30% of patients in the present study,
tomographic information regarding myocardial viability con-
tributed at least in part a decision on whether or not to
proceed with coronary revascularization . Consequently, the
number of cases in which dysfunctional segments were
correctly identified as nonviable myocardium by PET with
' 8
F-fluorodeoxyglucose may have been underrepresented.
However, a similar bias would have also been present for the
criteria based on PET with 11C-acetate . The use of different
methods to measure mechanical function before and after
coronary revascularization in eight of the patients could
have increased the number of discordances between the
tomographic criteria of tissue viability and functional out-
come (see Results) . However, the assessment of regional
systolic function was reproducible despite the use of differ-
ent imaging methods . Moreover, the accuracy of the tomo-
graphic criteria for identifying viable myocardium in se-
verely dysfunctional segments (positive and negative
predictive values of 73% and 80%, respectively) for 18F
efluorodeoxyglucos  and of 80% and 87%, respectively, for
1 &C-acetate in the 26 patients in whom the paired echocar-
diograms or radionuclide ventriculograms were used to
determine the functional response to revascularization was
comparable to that of the group as a whole . Thus, it is
unlikely that using different methods to assess mechanical
Wall Motion
(no . of segments)
Improved
Not
Improved
Predictive
Value (%)
Fluorine- 18-fluorodeoxyglucose
Viable 21 8 72
Nonviable 5 23 82
Carbon- I I-acetate
Viable 22 4 85
Nonviable 4 27 87
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.
function before and after revascularization had a significant
impact on the accuracy of the tomographic criteria for
viability .
Myocardial with 11C-acetate: technical consider .
In addition to improved accuracy in differentiating
dysfunctional but viable from nonviable myocardium, PET
with ITC-acetate affords logistic advantages relative to PET
with
1®
F-fluorodeoxyglucose . The duration of a complete
tomographic study with 11C-acetate is approximately 45 min,
during which both relative myocardial blood flow and re-
gional myocardial oxidative metabolism can be assessed . In
contrast, a viability study with 15F-fluorodeoxyglucose re-
quires 2 h and the use of another radiopharmaceutical (for
example, t 50-water, 1IN-ammonia or s2rubidium) for assess-
ment of perfusion . The insensitivity of
I
IC-acetate kinetics in
myocardium to the pattern of substrate delivery (31) is an
additional advantage . However, these advantages are some-
what counterbalanced by the need for more frequent synthe-
sis of the radiopharmaccutical (physical half-life 20 .3 min for
carbon- l l vs . 109.9 min for fluorine- 18) and slightly more
intensive computer processing and data analysis,
The extent of improvement in global left ventricular
function and clinical outcome after revascularization are
related in part to the extent of dysfunctional but still viable
myocardium present initially (2,32,33). Positron emission
tomography and 18F-fluorodeoxygiucose can identify pa-
tients with left ventricular dysfunction due to coronary
artery disease in whom successful coronary revasculariza-
tion will result in an increase in left ventricular ejection
traction and an improvement in functional class (2,33) .
Moreover, patients who are at high risk for future cardiac
events can be identified (33). Thus, the improved identifica-
tion of left ventricular segments that contain dysfunctional
but still viable myocardium by PET with 11C-acetate should
facilitate the objective assessment of the need to revascular-
ize myocardium and interventions designed to restore myo-
cardial perfusion, thereby improving patient selection for
coronary revascularization,
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